ADC Therapeutics
Climate Impact & Sustainability Data (2021)
Reporting Period: 2021
Environmental Metrics
ESG Focus Areas
- Patients
- Human Capital
- Diversity & Inclusion
- Health and Safety
- Employee Engagement
- Leadership, Governance and Ethics
- Community
- Product Quality & Safety
- Cybersecurity, Privacy and Data Management
- Environment
Environmental Achievements
- New London research labs housed in a building with a BREEAM rating of “excellent” and an Energy Performance Certificate rating of “B”.
Social Achievements
- Comprehensive patient support program, ADVANCING Patient Support, including coverage support, financial support, and nursing support.
- Flexible work environment reducing employee commuting pollution.
- Partnerships with the Leukemia & Lymphoma Society (LLS) and the Leukemia Research Foundation (LRF).
Governance Achievements
- Robust compliance program following the Office of Inspector General Compliance Program Guidance for Pharmaceutical Manufacturers.
- Anonymous Compliance hotline for employees.
- Due diligence for designated third parties.
- Comprehensive Code of Business Conduct and Ethics.
Climate Goals & Targets
Environmental Challenges
- Global cybersecurity threats.
- Minimizing environmental impact as the company grows.
Mitigation Strategies
- Increased network security measures and annual cybersecurity training for employees.
- Implementing environmentally conscious design in new facilities, promoting flexible work arrangements to reduce commuting.
Supply Chain Management
Responsible Procurement
- Holding product supply partners to high GxP standards through a robust quality management system and supplier qualification process.